Deep learning facilitated discovery of prognosis biomarkers and their ligands to improve liver cancer treatment
DLCP provides a successful example of introducing DL into cancer prognosis by incorporating heterogeneous multi-omics and clinical phenotype, highlights the molecular mechanism of HCC progression, and accelerates the discovery of drug candidate molecules.
Authors
- Sheng-Zhen Li
- Qi-Hao Li
- Ji‐Jun Chen
- Tian-Ze Li (ORCID: https://orcid.org/0000-0002-8209-958X)
- Yongcui Wang (ORCID: https://orcid.org/0000-0002-2528-5714)
Institutions
- Kunming Institute of Botany (CN)
- GTx (United States) (US)
- University of Chinese Academy of Sciences (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-09-12
- DOI
- https://doi.org/10.1097/js9.0000000000003455
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00